Glossary
Clear definitions for PK/PD concepts, study design terms, and peptide pharmacology.
ADME
See also: pharmacokinetics, bioavailability, half-life
Agonist
See also: Antagonist
Animal model
Definition
Antagonist
See also: Agonist
AUC (Area Under the Curve)
See also: bioavailability, clearance, half-life, pharmacokinetics
Bioavailability
See also: pharmacokinetics, half-life
Clearance (CL)
See also: volume-of-distribution, half-life, pharmacokinetics, auc
Cmax
See also: pharmacokinetics, bioavailability, half-life
DOI (Digital Object Identifier)
Definition
First-Pass Metabolism
See also: bioavailability, pharmacokinetics, clearance
Half-life
See also: Pharmacokinetics (PK), Bioavailability
In vitro
Definition
Intramuscular
See also: subcutaneous, intravenous, bioavailability
Intravenous
See also: subcutaneous, intramuscular, bioavailability
Lyophilization
See also: reconstitution, storage
Meta-analysis
See also: Systematic review
Observational study
See also: Randomized controlled trial (RCT)
Pharmacodynamics (PD)
See also: Pharmacokinetics (PK), Agonist, Antagonist
Pharmacokinetics (PK)
See also: Pharmacodynamics (PD), Half-life, Bioavailability
PMID
Definition
Randomized controlled trial (RCT)
See also: Observational study
Receptor
See also: agonist, antagonist, pharmacodynamics
Subcutaneous
See also: intramuscular, intravenous, bioavailability
Systematic review
See also: Meta-analysis
Tmax (Time to Maximum Concentration)
See also: Cmax, absorption, half-life
Volume of Distribution (Vd)
See also: clearance, half-life, pharmacokinetics